Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A cardiac microRNA governs systemic energy homeostasis by regulation of MED13.

Cell | 2012

Obesity, type 2 diabetes, and heart failure are associated with aberrant cardiac metabolism. We show that the heart regulates systemic energy homeostasis via MED13, a subunit of the Mediator complex, which controls transcription by thyroid hormone and other nuclear hormone receptors. MED13, in turn, is negatively regulated by a heart-specific microRNA, miR-208a. Cardiac-specific overexpression of MED13 or pharmacologic inhibition of miR-208a in mice confers resistance to high-fat diet-induced obesity and improves systemic insulin sensitivity and glucose tolerance. Conversely, genetic deletion of MED13 specifically in cardiomyocytes enhances obesity in response to high-fat diet and exacerbates metabolic syndrome. The metabolic actions of MED13 result from increased energy expenditure and regulation of numerous genes involved in energy balance in the heart. These findings reveal a role of the heart in systemic metabolic control and point to MED13 and miR-208a as potential therapeutic targets for metabolic disorders.

Pubmed ID: 22541436 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: RL1 DK081185
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL053351
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL111665
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL111665-02
  • Agency: NIDDK NIH HHS, United States
    Id: RL1DK081185
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL061544-05
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL053351-05
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL077439-09
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL083371-05
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL077439
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL093039-03S1
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL077439-10
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL053351-15
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL053351
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL083371
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR040339-11S1
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL083371-04W1
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL061544-04
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL093039
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR040339-11
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL083371-04
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024923
  • Agency: NIDDK NIH HHS, United States
    Id: PL1 DK081182
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL053351-14

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Ingenuity Pathways Knowledge Base (tool)

RRID:SCR_008117

A horizontally and vertically structured database that pulls scientific and medical information and describes it consistently using the Ingenuity Ontology. The Knowledge Base pulls information from journals, public molecular content databases, and textbooks. Data is curated and and integrated into the Knowledge Base .

View all literature mentions